Potential screening assays for individual radiation sensitivity and susceptibility and their current validation state

References

• Abend M, Badie C, Quintens R, Kriehuber R, Manning G, Macaeva E, Njima M, Oskamp D, Strunz S, Moertl S, et al. 2016. Examining radiation-induced in vivo and in vitro gene expression changes of the peripheral blood in different laboratories for biodosimetry purposes: first RENEB gene expression study. Radiat Res. 185:109–123.
   PubMed Web of Science ®Google Scholar
• Ainsbury E, Bouffler S, Dörr W, Graw J, Muirhead C, Edwards A, Cooper J. 2009. Radiation cataractogenesis: a review of recent studies. Radiat Res. 172:1–9.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, et al., International Radiogenomics Consortium (RgC). 2016a. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol. 121:431–439.
   PubMed Web of Science ®Google Scholar
• Andreassen C, Schack L, Laursen L, Alsner J. 2016b. Radiogenomics - current status, challenges and future directions. Cancer Lett. 382:127–136.
   PubMed Web of Science ®Google Scholar
• Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, et al. 2017. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 376:1835–1848.
   PubMed Web of Science ®Google Scholar
• Azimzadeh O, Azizova T, Merl-Pham J, Subramanian V, Bakshi MV, Moseeva M, Zubkova O, Hauck SM, Anastasov N, Atkinson MJ, et al. 2017. A dose-dependent perturbation in cardiac energy metabolism is linked to radiation-induced ischemic heart disease in Mayak nuclear workers. Oncotarget. 8:9067–9078.
   PubMed Web of Science ®Google Scholar
• Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, Moscardo C, Lemanski C, Coelho M, Rosenstein B, et al. 2010. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol. 11:258–265.
   PubMed Web of Science ®Google Scholar
• Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton N, Mornex F, Pèlegrin A, Dubois J-B, Mirimanoff R-O, et al. 2008. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res. 14:6284–6288.
   PubMed Web of Science ®Google Scholar
• Azria D, Riou O, Castan F, Nguyen T, Peignaux K, Lemanski C, Lagrange J-L, Kirova Y, Lartigau E, Belkacemi Y, et al. 2015. Radiation-induced CD8 T-lymphocyte apoptosis as a predictor of breast fibrosis after radiotherapy: results of the prospective Multicenter French Trial. EBioMedicine. 2:1965–1973.
   PubMed Web of Science ®Google Scholar
• Badie C, Goodhardt M, Waugh A, Doyen N, Foray N, Calsou P, Singleton B, Gell D, Salles B, Jeggo P, et al. 1997. A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype. Cancer Res. 57:4600–4607.
   PubMed Web of Science ®Google Scholar
• Badie C, Iliakis G, Foray N, Alsbeih G, Pantellias G, Okayasu R, Cheong N, Russell N, Begg A, Arlett C. 1995. Defective repair of DNA double-strand breaks and chromosome damage in fibroblasts from a radiosensitive leukemia patient. Cancer Res. 55:1232–1234.
   PubMed Web of Science ®Google Scholar
• Badie C, Kabacik S, Balagurunathan Y, Bernard N, Brengues M, Faggioni G, Greither R, Lista F, Peinnequin A, Poyot T, et al. 2013. Laboratory intercomparison of gene expression assays. Radiat Res. 181:138–148.
   Google Scholar
• Baijer J, Déchamps N, Perdry H, Morales P, Kerns S, Vasilescu A, Baulande S, Azria D, Roméo P, Schmitz A. 2016. TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis. Oncotarget. 7:21416–21427.
   PubMedGoogle Scholar
• Bakhmutsky MV, Joiner MC, Jones TB, Tucker JD. 2014. Differences in cytogenetic sensitivity to ionizing radiation in newborns and adults. Radiat Res. 181:605–616.
   PubMed Web of Science ®Google Scholar
• Baria K, Warren C, Roberts S, West C, Scott D. 2001. Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer. 84:892–896.
   PubMed Web of Science ®Google Scholar
• Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, et al. 2014. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiother Oncol. 111:178–185.
   PubMed Web of Science ®Google Scholar
• Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Loo P, Alexandrov LB, Ramakrishna M, Davies H, et al. 2016. Mutational signatures of ionizing radiation in second malignancies. Nat Commun. 7:12605.
   PubMed Web of Science ®Google Scholar
• Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, et al. 2019. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 37:453–460.
   PubMed Web of Science ®Google Scholar
• Benafif S, Kote-Jarai Z, Eeles RA, PRACTICAL Consortium. 2018. A review of prostate cancer genome-wide association studies (GWAS). Cancer Epidemiol Biomarkers Prev. 27:845–857.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. 2006. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 6:702–713.
   PubMed Web of Science ®Google Scholar
• Bernstein JL, Concannon P, WECARE Study Collaborative Group. 2017. ATM, radiation, and the risk of second primary breast cancer. Int J Radiat Biol. 93:1121–1127.
   PubMed Web of Science ®Google Scholar
• Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, Yasui Y, Bhatia S, Strong LC, mchek S, Nathanson KL, et al. 2011. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin’s lymphoma. Nat Med. 17:941–943.
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, Kuulasmaa K, Yarnell J, Schnabel RB, Wild PS, et al. 2010. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation. 121:2388–2397.
   PubMed Web of Science ®Google Scholar
• Bordón E, Henríquez-Hernández L, Lara P, Pinar B, Rodríguez-Gallego C, Lloret M. 2011. Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and natural killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients. Int J Radiat Biol. 87:424–431.
   PubMed Web of Science ®Google Scholar
• Bordón E, Henríquez-Hernández L, Lara PC, Ruíz A, Pinar B, Rodríguez-Gallego C, Lloret M. 2010. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs). Radiat Oncol. 5:4.
   PubMed Web of Science ®Google Scholar
• Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio M, Carosella ED. 2005. Genetic and epigenetic features in radiation sensitivity. Eur J Nucl Med Mol Imaging. 32:351–368.
   PubMed Web of Science ®Google Scholar
• Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. 2011. Prolonged expression of the γH2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer. 129:2928–2934.
   PubMed Web of Science ®Google Scholar
• Brandmaier A, Hou S-Q, Demaria S, Formenti SC, Shen WH. 2017. PTEN at the interface of immune tolerance and tumor suppression. Front Biol. 12:163–174.
   Google Scholar
• Brengues M, Lapierre A, Bourgier C, Pèlegrin A, Özsahin M, Azria D. 2017. T lymphocytes to predict radiation-induced late effects in normal tissues. Expert Rev Mol Diagn. 17:119–127.
   PubMed Web of Science ®Google Scholar
• Britel M, Bourguignon M, Foray N. 2018. The use of the term ‘radiosensitivity’ through history of radiation: from clarity to confusion. Int J Radiat Biol. 94:1–31.
   PubMed Web of Science ®Google Scholar
• Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit K. 2010. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biology Phys. 76:1005–1011.
   PubMed Web of Science ®Google Scholar
• Brzozowska K, Pinkawa M, Eble MJ, Müller W-U, Wojcik A, Kriehuber R, Schmitz S. 2012. In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy. Int J Radiat Biol. 88:405–413.
   PubMed Web of Science ®Google Scholar
• Chen Y, Trotti A, Coleman NC, Machtay M, Mirimanoff RO, Hay J, O’Brien PC, El-Gueddari B, Salvajoli JV, Jeremic B. 2006. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation. Int J Radiat Oncol Biology Phys. 64:1442–1451.
   Web of Science ®Google Scholar
• Chin MS, Freniere BB, Lancerotto L, Lujan-Hernandez J, Saleeby JH, Lo Y-C, Orgill DP, Lalikos JF, Fitzgerald TJ. 2015. Hyperspectral imaging as an early biomarker for radiation exposure and microcirculatory damage. Front Oncol. 5:232.
   PubMed Web of Science ®Google Scholar
• Chin MS, Siegel-Reamer L, FitzGerald GA, Wyman A, Connor NM, Lo Y-C, Sioshansi S, Moni J, Cicchetti MG, Lalikos JF, et al. 2017. Association between cumulative radiation dose, adverse skin reactions, and changes in surface hemoglobin among women undergoing breast conserving therapy. Clin Transl Radiat Oncol. 4:15–23.
   PubMed Web of Science ®Google Scholar
• Constine LS, Ronckers CM, Hua C-H, Olch A, Kremer LCM, Jackson A, Bentzen SM. 2019. Pediatric Normal Tissue Effects in the Clinic (PENTEC): an international collaboration to analyse normal tissue radiation dose-volume response relationships for paediatric cancer patients. Clin Oncol (R Coll Radiol). 31:199–207.
   PubMed Web of Science ®Google Scholar
• Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, Hyman DM, Solit DB, Robson ME, Baselga J, et al. 2017. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 21:374–382.e4.
   PubMed Web of Science ®Google Scholar
• Cosset J-M, Hetnal M, Chargari C. 2018. Second cancers after radiotherapy: update and recommandations. Radioprotection. 53:101–105.
   Web of Science ®Google Scholar
• Crompton NE, Ozsahin M. 1997. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res. 147:55–60.
   PubMed Web of Science ®Google Scholar
• de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E. 2011. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 12:353–360.
   PubMed Web of Science ®Google Scholar
• Desai P, Mencia-Trinchant N, Savenkov O, Simon MS, Cheang G, Lee S, Samuel M, Ritchie EK, Guzman ML, Ballman KV, et al. 2018. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med. 24:1015–1023.
   PubMed Web of Science ®Google Scholar
• Djuzenova CS, Elsner I, Katzer A, Worschech E, Distel LV, Flentje M, Polat B. 2013. Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci. Radiat Oncol. 8:98.
   PubMed Web of Science ®Google Scholar
• Djuzenova CS, Zimmermann M, Katzer A, Fiedler V, Distel LV, Gasser M, Waaga-Gasser A-M, Flentje M, Polat B. 2015. A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome. BMC Cancer. 15:856.
   PubMed Web of Science ®Google Scholar
• Emanueli C, Shearn A, Angelini GD, Sahoo S. 2015. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascul Pharmacol. 71:24–30.
   PubMed Web of Science ®Google Scholar
• European Commission High Level and Expert Group. 2009. EUR 23884—HLEG report on European Low Dose Risk Research Radiation Protection. Luxembourg: Office for Official Publications of the European Communities. Available at: https://cordis.europa.eu/docs/publications/1070/107087891-6_en.pdf.
   Google Scholar
• Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, et al. 2014. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet. 46:891–894.
   PubMed Web of Science ®Google Scholar
• Ferlazzo ML, Bourguignon M, Foray N. 2017. Functional assays for individual radiosensitivity: a critical review. Semin Radiat Oncol. 27:310–315.
   PubMed Web of Science ®Google Scholar
• Fleckenstein J, Kühne M, Seegmüller K, Derschang S, Melchior P, Gräber S, Fricke A, Rübe CE, Rübe C. 2011. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biology Phys. 81:1465–1472.
   PubMed Web of Science ®Google Scholar
• Floyd DN, Cassoni AM. 1994. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur J Cancer. 30:615–620.
   Google Scholar
• Foray N, Bourguignon M, Hamada N. 2016. Individual response to ionizing radiation. Mutat Res. 770:369–386.
   PubMed Web of Science ®Google Scholar
• Foro P, Algara M, Lozano J, Rodriguez N, Sanz X, Torres E, Carles J, Reig A, Membrive I, Quera J, et al. 2014. Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study. Int J Radiat Oncol Biology Phys. 88:1057–1063.
   PubMed Web of Science ®Google Scholar
• Friedman DL, Kadan-Lottick NS, Whitton J, Mertens AC, Yasui Y, Liu Y, Meadows AT, Robison LL, Strong LC. 2005. Increased risk of cancer among siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 14:1922–1927.
   PubMed Web of Science ®Google Scholar
• Fucic A, Brunborg G, Lasan R, Jezek D, Knudsen LE, Merlo DF. 2008. Genomic damage in children accidentally exposed to ionizing radiation: a review of the literature. Mutat Res Rev Mutat Res. 658:111–123.
   PubMed Web of Science ®Google Scholar
• Fuentes-Raspall MJ, Caragol I, Alonso C, y Cajal T, Fisas D, Seoane A, Carvajal N, Bonache S, Díez O, Gutiérrez-Enríquez S. 2015. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism. Apoptosis. 20:371–382.
   PubMed Web of Science ®Google Scholar
• Furutani E, Shimamura A. 2017. Germline genetic predisposition to hematologic malignancy. J Clin Oncol. 35:1018–1028.
   PubMed Web of Science ®Google Scholar
• Gomolka M, Oestreicher U, Rößler U, Samaga D, Endesfelder D, Lang P, Neumaier K, Belka C, Niemeyer M, Kiechle M, et al. 2018. Age-dependent differences in DNA damage after in vitro CT exposure. Int J Radiat Biol. 94:272–282.
   PubMed Web of Science ®Google Scholar
• Goutham H, Mumbrekar K, Vadhiraja B, Fernandes D, Sharan K, Parashiva G, Kapaettu S, Sadashiva S. 2012. DNA double-strand break analysis by γ-H2AX foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients. Int J Radiat Oncol Biology Phys. 84:e607–e612.
   PubMed Web of Science ®Google Scholar
• Granzotto A, Benadjaoud M, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, et al. 2016. Influence of nucleoshuttling of the ATM protein in the healthy tissues response to radiation therapy: toward a molecular classification of human radiosensitivity. Int J Radiat Oncol Biology Phys. 94:450–460.
   PubMed Web of Science ®Google Scholar
• Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, et al. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 15:565–574.
   PubMed Web of Science ®Google Scholar
• Greve B, Bölling T, Amler S, Rössler U, Gomolka M, Mayer C, Popanda O, Dreffke K, Rickinger A, Fritz E, et al. 2012. Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison–lessons for future studies. PLoS One. 7:e47185.
   PubMed Web of Science ®Google Scholar
• Habash M, Bohorquez LC, Kyriakou E, Kron T, Martin OA, Blyth BJ. 2017. Clinical and functional assays of radiosensitivity and radiation-induced second cancer. Cancers. 9:147.
   Web of Science ®Google Scholar
• Hadj-Hamou N-S, Ugolin N, Ory C, Britzen-Laurent N, Sastre-Garau X, Chevillard S, Malfoy B. 2011. A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas. Carcinogenesis. 32:929–934.
   PubMed Web of Science ®Google Scholar
• Hall J, Jeggo PA, West C, Gomolka M, Quintens R, Badie C, Laurent O, Aerts A, Anastasov N, Azimzadeh O, et al. 2017. Ionizing radiation biomarkers in epidemiological studies – an update. Mutat Res Rev Mutat Res. 771:59–84.
   PubMed Web of Science ®Google Scholar
• Hamada N. 2017. Ionizing radiation sensitivity of the ocular lens and its dose rate dependence. Int J Radiat Biol. 93:1024–1034.
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. 2013. Human radiosensitivity: a report of the independent advisory group on ionising radiation. Available at: https://assets.publishing.service.gov.uk/government/…/RCE-21_v2_for_website.pdf.
   Google Scholar
• Hollstein M, Hupp T. 2011. Chek2ing out the p53 pathway: can Puma lead the way? Cell Cycle. 10:1524.
   PubMed Web of Science ®Google Scholar
• Hourigan CS, Savani BN. 2018. Leukaemia risk associated with low-dose radiation. Lancet Haematol. 5:e324–e325.
   PubMed Web of Science ®Google Scholar
• Hubenak JR, Zhang Q, Branch CD, Kronowitz SJ. 2014. Mechanisms of injury to normal tissue after radiotherapy: a review. Plast Reconstr Surg. 133:49e–56e.
   PubMed Web of Science ®Google Scholar
• ICRP. 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 37:1–332.
   Google Scholar
• Ioannidis JP, Bossuyt PM. 2017. Waste, leaks, and failures in the biomarker pipeline. Clin Chem. 63:963–972.
   PubMed Web of Science ®Google Scholar
• Ishihara S, Iinuma H, Fukushima Y, Akahane T, Horiuchi A, Shimada R, Shibuya H, Hayama T, Yamada H, Nozawa K, et al. 2012. Radiation-induced apoptosis of peripheral blood lymphocytes is correlated with histological regression of rectal cancer in response to preoperative chemoradiotherapy. Ann Surg Oncol. 19:1192–1198.
   PubMed Web of Science ®Google Scholar
• Jacob S. 2012. Ionizing radiation as a risk factor for cataract: what about low-dose effects? J Clin Exp Ophthalmol. S1:005.
   Google Scholar
• Kabacik S, Manning G, Raffy C, Bouffler S, Badie C. 2015. Time, dose and ataxia telangiectasia mutated (ATM) status dependency of coding and noncoding RNA expression after ionizing radiation exposure. Radiat Res. 183:325–337.
   PubMed Web of Science ®Google Scholar
• Kabacik S, Ortega-Molina A, Efeyan A, Finnon P, Bouffler S, Serrano M, Badie C. 2011. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity. Cell Cycle. 10:1152–1161.
   PubMed Web of Science ®Google Scholar
• Kan C, Zhang J. 2015. BRCA1 mutation: a predictive marker for radiation therapy? Int J Radiat Oncol Biol Phys. 93:281–293.
   PubMed Web of Science ®Google Scholar
• Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, et al., Radiogenomics Consortium. 2016. Meta-analysis of Genome Wide Association Studies identifies genetic markers of late toxicity following radiotherapy for prostate cancer. EBioMedicine. 10:150–163.
   PubMed Web of Science ®Google Scholar
• Kessler T, Vilne B, Schunkert H. 2016. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease . Embo Mol Med. 8:688–701.
   PubMed Web of Science ®Google Scholar
• Kovacic S, Bakran M. 2012. Genetic susceptibility to atherosclerosis. Stroke Res Treat. 2012:362941.
   PubMedGoogle Scholar
• Kreuzer M, Auvinen A, Cardis E, Durante M, Harms-Ringdahl M, Jourdain JR, Madas BG, Ottolenghi A, Pazzaglia S, Prise KM, et al. 2018. Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research. Radiat Environ Biophys. 57:5–15.
   PubMed Web of Science ®Google Scholar
• Kreuzer M, Auvinen A, Cardis E, Hall J, Jourdain J-R, Laurier D, Little MP, Peters A, Raj K, Russell NS, et al. 2015. Low-dose ionising radiation and cardiovascular diseases-Strategies for molecular epidemiological studies in Europe. Mutat Res Rev Mutat Res. 764:90–100.
   PubMed Web of Science ®Google Scholar
• Leng S, Picchi MA, Liu Y, Thomas CL, Willis DG, Bernauer AM, Carr TG, Mabel PT, Han Y, Amos CI, et al. 2013. Genetic variation in SIRT1 affects susceptibility of lung squamous cell carcinomas in former uranium miners from the Colorado plateau. Carcinogenesis. 34:1044–1050.
   PubMed Web of Science ®Google Scholar
• Leng S, Thomas CL, Snider AM, Picchi MA, Chen W, Willis DG, Carr TG, Krzeminski J, Desai D, Shantu A, et al. 2016. Radon exposure, IL-6 promoter variants, and lung squamous cell carcinoma in former uranium miners. Environ Health Persp. 124:445–451.
   PubMed Web of Science ®Google Scholar
• Li C, Athar M. 2016. Ionizing radiation exposure and basal cell carcinoma pathogenesis. Radiat Res. 186:217–228.
   Google Scholar
• Li P, Du C, Xu W, Shi Z, Zhang Q, Li Z, Fu S. 2013. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis. Radiat Oncol. 8:155.
   PubMed Web of Science ®Google Scholar
• Lobachevsky P, Leong T, Daly P, Smith J, Best N, Tomaszewski J, Thompson ER, Li N, Campbell IG, Martin RF, et al. 2016. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity. Cancer Lett. 383:212–219.
   PubMed Web of Science ®Google Scholar
• Loh P-R, Genovese G, Handsaker RE, Finucane HK, Reshef YA, Palamara P, Birmann BM, Talkowski ME, Bakhoum SF, McCarroll SA, et al. 2018. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature. 559:350–355.
   PubMed Web of Science ®Google Scholar
• Manning G, Kabacik S, Finnon P, Bouffler S, Badie C. 2013. High and low dose responses of transcriptional biomarkers in ex vivo X-irradiated human blood. Int J Radiat Biol. 89:512–522.
   PubMed Web of Science ®Google Scholar
• Marcu LG. 2017. Photons – radiobiological issues related to the risk of second malignancies. Phys Med. 42:213–220.
   PubMed Web of Science ®Google Scholar
• Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD. 2009. Second neoplasms in survivors of childhood cancer: findings from the childhood cancer survivor study cohort. J Clin Oncol. 27:2356–2362.
   PubMed Web of Science ®Google Scholar
• Mertens AC, Mitby PA, Radloff G, Jones IM, Perentesis J, Kiffmeyer WR, Neglia JP, Meadows A, Potter JD, Friedman D, et al. 2004. XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer. 101:1463–1472.
   PubMed Web of Science ®Google Scholar
• Milano MT, Constine LS, Okunieff P. 2007. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol. 17:131–140.
   PubMed Web of Science ®Google Scholar
• Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, et al. 2017. Genome-wide association study to identify susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer. J Natl Cancer Inst. 109.
   Google Scholar
• Mumbrekar K, Fernandes D, Goutham H, Sharan K, Vadhiraja B, Satyamoorthy K, Sadashiva S. 2014. Influence of double-strand break repair on radiation therapy-induced acute skin reactions in breast cancer patients. Int J Radiat Oncol Biol Phys. 88:671–676.
   PubMed Web of Science ®Google Scholar
• Neriishi K, Hayashi T, Nakashima E, Imai K, Nakachi K. 2009. ATM haplotypes and radiosensitivity in A-bomb survivors: preliminary trial using existing data at RERF. Abstract Book of Radiation Cataractogenesis Workshop. Hiroshima, Japan: RERF.
   Google Scholar
• O'Brien G, Cruz-Garcia L, Majewski M, Grepl J, Abend M, Port M, Tichý A, Sirak I, Malkova A, Donovan E, et al. 2018. FDXR is a biomarker of radiation exposure in vivo. Sci Rep. 8:684.
   PubMed Web of Science ®Google Scholar
• Oestreicher U, Endesfelder D, Gomolka M, Kesminiene A, Lang P, Lindholm C, Rößler U, Samaga D, Kulka U. 2018. Automated scoring of dicentric chromosomes differentiates increased radiation sensitivity of young children after low dose CT exposure in vitro. Int J Radiat Biol. 94:1017–1026.
   PubMed Web of Science ®Google Scholar
• Olsson CE, Jackson A, Deasy JO, Thor M. 2018. A systematic post-QUANTEC review of tolerance doses for late toxicity after prostate cancer radiotherapy. Int J Radiat Oncol Biology Phys. 102:1514–1532.
   PubMed Web of Science ®Google Scholar
• Ordoñez R, Henríquez-Hernández LA, Federico M, Valenciano A, Pinar B, Lloret M, Bordón E, Rodríguez-Gallego C, Lara PC. 2014. Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients. Strahlenther Onkol. 190:210–216.
   PubMed Web of Science ®Google Scholar
• Ory C, Ugolin N, Levalois C, Lacroix L, Caillou B, Bidart J-M, Schlumberger M, Diallo I, de Vathaire F, Hofman P, et al. 2011. Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr Relat Cancer 18:193–206.
   PubMed Web of Science ®Google Scholar
• Ozsahin M, Crompton N, Gourgou S, Kramar A, Li L, Shi Y, Sozzi W, Zouhair A, Mirimanoff RO, Azria D. 2005. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res. 11:7426–7433.
   PubMed Web of Science ®Google Scholar
• Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo ML, Devic C, Granzotto A, Deneuve S, Vogin G, Foray N. 2018. Fast and binary assay for predicting radiosensitivity based on the theory of ATM nucleo-shuttling: development, validation, and performance. Int J Radiat Oncol Biology Phys. 100:353–360.
   PubMed Web of Science ®Google Scholar
• Pérez-Losada J, Castellanos-Martín A, Mao J-H. 2011. Cancer evolution and individual susceptibility. Integr Biol (Camb). 3:316–328.
   PubMed Web of Science ®Google Scholar
• Pointreau Y, Kreps S, Hennequin C. 2010. Évaluation des effets secondaires des radiations ionisantes. Cancer Radiothér. 14:246–249.
   PubMedGoogle Scholar
• Rajaraman P, Hauptmann M, Bouffler S, Wojcik A. 2018. Human individual radiation sensitivity and prospects for prediction. Ann ICRP. 47:126–141.
   PubMedGoogle Scholar
• Repussard J. 2017. Low dose effects research in Europe: eight years of evolution towards new paradigms. Radioprotection. 52:251–258.
   Web of Science ®Google Scholar
• Rosenberger A, Hung RJ, Christiani DC, Caporaso NE, Liu G, Bojesen SE, Le Marchand L, Haiman CA, Albanes D, Aldrich MC, et al. 2018. Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health. 91:937–950.
   PubMed Web of Science ®Google Scholar
• Rosenblatt E, Izewska J, Anacak Y, Pynda Y, Scalliet P, Boniol M, Autier P. 2013. Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centers (DIRAC) database. Lancet Oncol. 14:e79–e86.
   PubMed Web of Science ®Google Scholar
• Schmitz A, Bayer J, Dechamps N, Goldin L, Thomas G. 2007. Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys. 68:1169–1177.
   PubMed Web of Science ®Google Scholar
• Schnarr K, Boreham D, Sathya J, Julian J, Dayes IS. 2009. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients. Int J Radiat Oncol Biol Phys. 74:1424–1430.
   PubMed Web of Science ®Google Scholar
• Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, et al. 2015. XRCC1 polymorphism associated with late toxicity after radiation therapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 92:1084–1092.
   PubMed Web of Science ®Google Scholar
• Shore RE, Neriishi K, Nakashima E. 2010. Epidemiological studies of cataract risk at low to moderate radiation doses: (not) seeing is believing. Radiat Res. 181:889–894.
   Google Scholar
• Sigurdson AJ, Stram DO. 2012. Genetic predisposition to radiation-related cancer and potential implications for risk assessment. Ann ICRP. 41:108–116.
   PubMedGoogle Scholar
• Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W, Paganetti H. 2007. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res. 167:12–42.
   PubMed Web of Science ®Google Scholar
• Talbot C, Tanteles G, Barnett G, Burnet N, Chang-Claude J, Coles C, Davidson S, nning A, Mills J, Murray R, et al. 2012. A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy. Br J Cancer. 107:748–753.
   PubMed Web of Science ®Google Scholar
• Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong J-L, et al. 2009. Pten in stromal fibroblasts suppresses mammary epithelial tumors. Nature. 461:1084–1091.
   PubMed Web of Science ®Google Scholar
• Tsuruoka C, Blyth BJ, Morioka T, Kaminishi M, Shinagawa M, Shimada Y, Kakinuma S. 2016. Sensitive detection of radiation-induced medulloblastomas after acute or protracted gamma-ray exposures in ptch1 heterozygous mice using a radiation-specific molecular signature. Radiat Res. 186:407–414.
   PubMed Web of Science ®Google Scholar
• UNSCEAR. 2008. Effects of ionizing radiation. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2006 Report, Vol. I. New York (NY): UNSCEAR.
   Google Scholar
• van Oorschot B, Hovingh S, Dekker A, Stalpers LJ, Franken NA. 2016. Predicting radiosensitivity with gamma-H2AX foci assay after single high-dose-rate and pulsed dose-rate ionizing irradiation. Radiat Res. 185:190–198.
   PubMed Web of Science ®Google Scholar
• van Oorschot B, Hovingh SE, Moerland PD, Medema J, Stalpers L, Vrieling H, Franken N. 2014. Reduced activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation toxicity. Int J Radiat Oncol Biol Phys. 88:664–670.
   PubMed Web of Science ®Google Scholar
• Vandevoorde C, Depuydt J, Veldeman L, Neve W, Sebastià N, Wieme G, Baert A, Langhe S, Philippé J, Thierens H, et al. 2016. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. Int J Radiat Biol. 92:823–836.
   PubMed Web of Science ®Google Scholar
• Verbiest T, Finnon R, Brown N, Cruz-Garcia L, Finnon P, O’Brien G, Ross E, Bouffler S, Scudamore CL, Badie C. 2018. Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis. Leukemia. 32:1435–1444.
   PubMed Web of Science ®Google Scholar
• Vogin G, Bastogne T, Bodgi L, Gillet-Daubin J, Canet A, Pereira S, Foray N. 2018. The pATM Immunofluorescence assay: a high-performance radiosensitivity assay to predict post radiotherapy overreactions. Int J Radiat Oncol Biol Phys. 101:690–693.
   PubMed Web of Science ®Google Scholar
• Waugh APW, Beare DM, Arlett CF, Green MHL, Cole J. 1991. Comparative human cellular radiosensitivity: IV. The increased sensitivity of human neonatal cord blood lymphocytes to γ-irradiation compared with lymphocytes from children and adults. Int J Radiat Biol. 59:767–776.
   PubMed Web of Science ®Google Scholar
• Werbrouck J, De Ruyck K, Beels L, Vral A, Van Eijkeren M, De Neve W, Thierens H. 2010. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the γ-H2AX foci assay and association with chromosomal radiosensitivity. Oncol Rep. 23:571–578.
   PubMed Web of Science ®Google Scholar
• West C, Azria D, Chang-Claude J, Davidson S, Lambin P, Rosenstein B, De Ruysscher D, Talbot C, Thierens H, Valdagni R, et al. 2014. The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors. Clin Oncol. 26:739–742.
   PubMed Web of Science ®Google Scholar
• West CM, Barnett GC. 2011. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 3:52.
   PubMed Web of Science ®Google Scholar
• West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang CJ, Chuang E, et al. 2010. Establishment of a radiogenomics consortium. Int J Radiat Oncol Biol Phys. 76:1295–1296.
   PubMed Web of Science ®Google Scholar
• Wirsdörfer F, de Leve S, Jendrossek V. 2018. Combining radiotherapy and immunotherapy in lung cancer: can we expect limitations due to altered normal tissue toxicity? Int J Mol Sci. 20:24.
   PubMed Web of Science ®Google Scholar
• Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, et al. 2015. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 518:552–555.
   PubMed Web of Science ®Google Scholar
• Zahnreich S, Ebersberger A, Karle H, Kaina B, Schmidberger H. 2016. Quantification of radiation biomarkers in leukocytes of breast cancer patients treated with different modalities of 3D-CRT or IMRT. Radiat Res. 186:508–519.
   PubMed Web of Science ®Google Scholar